🕵️ Edesa Biotech, Inc. ($EDSA)
SEC insider & ownership activity, last 12 months · CIK 1540159 · every row links its SEC filing
Insider buy value was withheld pending verification over the last 12 months. No red-flag 8-Ks in the window.
Insider flow
2 buyers, value withheld pending verification (9 lots) · 0 sellers, $0 (0 lots)
| Insider | Buys | Bought | Sells | Sold | Last |
|---|---|---|---|---|---|
| Nijhawan Pardeep | 8 | value withheld pending verification | 0 | – | Mar 10, 2026 |
| Michael J. Brooks | 1 | value withheld pending verification | 0 | – | Feb 26, 2026 |
5%+ holders
| Holder | Stake | Class | Schedule | Event | |
|---|---|---|---|---|---|
| Pardeep Nijhawan | 16.3% | 13D | Aug 21, 2026 | filing ↗ | |
| Velan Capital Investment Management LP | 10.0% | 13D | Aug 21, 2026 | filing ↗ | |
| Velan Capital Management LLC | 10.0% | 13D | Aug 21, 2026 | filing ↗ | |
| Morgan Adam | 10.0% | 13D | Aug 21, 2026 | filing ↗ | |
| Venkataraman Balaji | 10.0% | 13D | Aug 21, 2026 | filing ↗ | |
| Velan Capital Holdings LLC | 9.8% | 13D | Aug 21, 2026 | filing ↗ | |
| Velan Capital Master Fund LP | 8.0% | 13D | Aug 21, 2026 | filing ↗ | |
| Pardeep Nijhawan Medicine Professional Corporation | 7.8% | 13D | Aug 21, 2026 | filing ↗ | |
| Rubric Capital Management LP | 7.7% | 13G | May 15, 2026 | filing ↗ | |
| David Rosen | 7.7% | 13G | May 15, 2026 | filing ↗ | |
| Sirenia Capital Management LP | 7.2% | 13G | May 15, 2026 | filing ↗ | |
| Alex Silverstein | 7.2% | 13G | May 15, 2026 | filing ↗ | |
| Stonepine Capital Management, LLC | 6.9% | 13G | Aug 26, 2026 | filing ↗ | |
| Stonepine Capital, L.P. | 6.9% | 13G | Aug 26, 2026 | filing ↗ | |
| Stonepine GP, LLC | 6.9% | 13G | Aug 26, 2026 | filing ↗ | |
| Jon M. Plexico | 6.9% | 13G | Aug 26, 2026 | filing ↗ | |
| Perceptive Advisors LLC | 6.7% | 13G | Mar 16, 2026 | filing ↗ | |
| Joseph Edelman | 6.7% | 13G | Mar 16, 2026 | filing ↗ | |
| Perceptive Life Sciences Master Fund, Ltd. | 6.7% | 13G | Mar 16, 2026 | filing ↗ | |
| Integrated CORE Strategies (US) LLC | 5.4% | 13G | Jun 18, 2026 | filing ↗ | |
| Millennium Management LLC | 5.4% | 13G | Jun 18, 2026 | filing ↗ | |
| Millennium Group Management LLC | 5.4% | 13G | Jun 18, 2026 | filing ↗ | |
| Israel A. Englander | 5.4% | 13G | Jun 18, 2026 | filing ↗ | |
| Velan Capital Opportunity Fund II LLC | exited | 13D | Aug 21, 2026 | filing ↗ | |
| 1968160 Ontario Inc. | exited | 13D | Aug 21, 2026 | filing ↗ | |
| The Digestive Health Clinic Inc. | exited | 13D | Aug 21, 2026 | filing ↗ | |
| The New Nijhawan Family Trust 2015 | exited | 13D | Aug 21, 2026 | filing ↗ | |
| Velan Horizon Fund LP | exited | 13D | Aug 21, 2026 | filing ↗ | |
| Velan Horizon GP LLC | exited | 13D | Aug 21, 2026 | filing ↗ |
Planned insider sales (Form 144)
No sale notices filed in the last 12 months.
Material events (8-K)
| Item | Event date | |
|---|---|---|
| Material agreement (1.01) | Aug 19, 2026 | filing ↗ |
| Other events (8.01) | Aug 19, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Aug 19, 2026 | filing ↗ |
| Earnings (2.02) | Aug 13, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Aug 13, 2026 | filing ↗ |
| Material agreement (1.01) | Jun 10, 2026 | filing ↗ |
| Unregistered equity sale (3.02) | Jun 10, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Jun 10, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jun 10, 2026 | filing ↗ |
| Other events (8.01) | Jun 5, 2026 | filing ↗ |
| Officer/director changes (5.02) | May 27, 2026 | filing ↗ |
| Shareholder vote (5.07) | May 27, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | May 27, 2026 | filing ↗ |
| Earnings (2.02) | May 14, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | May 14, 2026 | filing ↗ |
| Officer/director changes (5.02) | May 13, 2026 | filing ↗ |
| Other events (8.01) | Feb 24, 2026 | filing ↗ |
| Earnings (2.02) | Feb 13, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Feb 13, 2026 | filing ↗ |
| Other events (8.01) | Dec 12, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Dec 12, 2025 | filing ↗ |
| Earnings (2.02) | Dec 12, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Dec 12, 2025 | filing ↗ |
| Other events (8.01) | Oct 28, 2025 | filing ↗ |
| Material agreement (1.01) | Sep 30, 2025 | filing ↗ |
| New financial obligation (2.03) | Sep 30, 2025 | filing ↗ |